Sign Up to Receive Your Personalised Learning Resources
Start Learning
Breakthroughs in melanoma: Highlights from ASCO 2024
Greatest Hits of 2024
FDA approval of nemolizumab gives new treatment option for prurigo nodularis
Baricitinib 4 mg delivers rapid, significant hair growth in adolescents with severe alopecia areata
3 Questions with Zenas Yiu: touchDERMATOLOGY Future Leader 2025
3 Questions with Jonathan Ho: touchDERMATOLOGY Future Leader 2025
Turning your Clinical Expertise into Business Success
3 questions with Antoni Gostyński: touchDERMATOLOGY Future Leader 2025
Barzolvolimab shows sustained efficacy over 52 weeks in antihistamine-refractory chronic spontaneous urticaria
#AAD25: Essential updates in atopic dermatitis and psoriasis
Sign up to view Favourites, Keep Notes and Track CME Credits
Favourites
Breaking new ground in CSU treatment: Highlights from EAACI 2024
View
Encouraging results for topical 1.5% ruxolitinib cream in milder cases of hidradenitis suppurativa
View
Advancing care for patients with infantile haemangiomas: Timing is key
View
Advancing global skin health: How the International Society of Dermatology is bridging gaps through education, outreach and collaboration
View
Introducing our newest Expert Faculty member: A leader in urticaria, drug allergies and angioedema
View
3 Questions with Neelam Vashi: touchDERMATOLOGY Future Leader 2025
View
Greatest Hits of 2024
View
Specific cord-blood DNA methylation patterns associated with risk of early-onset atopic dermatitis
View
#AAD25: Essential updates in atopic dermatitis and psoriasis
View
Ruxolitinib cream shows safe and lasting control in paediatric atopic dermatitis
View
Log into your Touch Account
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Sign up with an Email
Or use a .
This Functionality is for
Members Only
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
